Overview
Inspissated bile syndrome (IBS) is characterized by the thickening and obstruction of bile flow, typically due to neonatal or acquired factors, leading to jaundice, cholangitis, and potential liver damage 1.Diagnosis
Clinical signs include jaundice, abdominal distension, and elevated liver enzymes 1.
Imaging studies such as ultrasound and MRI cholangiopancreatography (MRCP) are crucial for visualizing bile duct obstruction 1.
Laboratory tests confirm elevated bilirubin and liver function abnormalities 1.Management
First-line treatment: Oral ursodeoxycholic acid (Ursofalk) is commonly used to thin bile 1.
Adjunctive treatments:
- Laparoscopic cholecystostomy with indwelling catheter for local Ursofalk flushing in refractory cases 1.
- Catheter placement allows for targeted therapy in the gallbladder and common bile duct 1.Special Populations
Pediatrics: Laparoscopic aided cholecystostomy shows promise as a minimally invasive approach in neonates unresponsive to oral medications 1.Key Recommendations
Consider laparoscopic cholecystostomy with indwelling catheter for neonates with inspissated bile syndrome who do not respond to oral ursodeoxycholic acid (Evidence: Weak) 1.
Continue oral ursodeoxycholic acid as first-line therapy for managing inspissated bile syndrome (Evidence: Expert opinion) 1.References
1 Gunnarsdóttir A, Holmqvist P, Arnbjörnsson E, Kullendorff CM. Laparoscopic aided cholecystostomy as a treatment of inspissated bile syndrome. Journal of pediatric surgery 2008. link